| 000 | 01754 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516152027.0 | ||
| 264 | 0 | _c20131024 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e32835cae3b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamorde, Mohammed | |
| 245 | 0 | 0 |
_aLower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cMar 2013 |
||
| 300 |
_a961-965 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimalarials _xadministration & dosage |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArtemether |
| 650 | 0 | 4 |
_aArtemisinins _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Antagonism |
| 650 | 0 | 4 |
_aEthanolamines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorenes _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aLumefantrine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 |
_aTuberculosis _xcomplications |
| 650 | 0 | 4 | _aUganda |
| 700 | 1 | _aByakika-Kibwika, Pauline | |
| 700 | 1 | _aMayito, Jonathan | |
| 700 | 1 | _aNabukeera, Lillian | |
| 700 | 1 | _aRyan, Mairin | |
| 700 | 1 | _aHanpithakpong, Warunee | |
| 700 | 1 | _aLefèvre, Gilbert | |
| 700 | 1 | _aBack, David J | |
| 700 | 1 | _aKhoo, Saye H | |
| 700 | 1 | _aMerry, Concepta | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 27 _gno. 6 _gp. 961-965 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e32835cae3b _zAvailable from publisher's website |
| 999 |
_c22772907 _d22772907 |
||